|Send to printer »|
The Lists: January 01, 0001 (Vol. , No. )
Top 10 M&A Deals of 2016
While 2016 Didn’t Reach the Heights Predicted, the Overall Value of Biopharma M&A Climbed
To enjoy more articles like this from GEN, click here to subscribe now!
© 2017 Genetic Engineering & Biotechnology News, All Rights Reserved